|4Jul 2, 11:02 AM ET

Koe Jan 4

4 · PROVECTUS PHARMACEUTICALS INC · Filed Jul 2, 2012

Insider Transaction Report

Form 4
Period: 2012-06-28
Koe Jan
Director
Transactions
  • Award

    Stock Option (right to buy)

    2012-06-28+50,00050,000 total
    Exercise: $0.84From: 2012-06-28Exp: 2022-06-28Common Stock (50,000 underlying)
  • Award

    Common Stock Warrants (right to buy)

    2012-06-28+100,000100,000 total
    Exercise: $1.25From: 2012-06-28Exp: 2016-04-15Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]The option grant was approved by the Board of Directors of Provectus Pharmaceuticals, Inc. (the "Company") on 5/14/12, subject to shareholder approval of the 2012 Stock Plan under which the option was granted. The Company's shareholders approved the 2012 Stock Plan on June 28, 2012.
  • [F2]The warrant was issued by the Company to the Reporting Person to replace an expired warrant. No pricing of the warrants has been done.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4